Targeting DNA damage and repair: Embracing the pharmacological era for successful cancer therapy
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference221 articles.
1. Preclinical evaluation of the tyrosine kinase inhibitor SU11248 as a single agent and in combination with “standard of care” therapeutic agents for the treatment of breast cancer;Abrams;Mol Cancer Ther,2003
2. Harnessing the complexity of DNA-damage response pathways to improve cancer treatment outcomes;Al-Ejeh;Oncogene,2010
3. Individual radiosensitivity and DNA repair proficiency: the value of the comet assay;Alapetite;Cancer Radiother,1998
4. Chlorambucil cytotoxicity in malignant B lymphocytes is synergistically increased by 2-(morpholin-4-yl)-benzo[h]chomen-4-one (NU7026)-mediated inhibition of DNA double-strand break repair via Inhibition of DNA-dependent protein kinase;Amrein;J Pharmacol Exp Ther,2007
5. Phase III randomized study comparing docetaxel plus trastuzumab with vinorelbine plus trastuzumab as first-line therapy of metastatic or locally advanced human epidermal growth factor receptor 2-positive breast cancer: the HERNATA study;Andersson;J Clin Oncol,2010
Cited by 82 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Dual Targeting of DNA Damage Response Proteins Implicated in Cancer Radioresistance;Genes;2023-12-17
2. New Facets of DNA Double Strand Break Repair: Radiation Dose as Key Determinant of HR versus c-NHEJ Engagement;International Journal of Molecular Sciences;2023-10-06
3. Improvement of radiotherapy with an ozone-carried liposome nano-system for synergizing cancer immune checkpoint blockade;Nano Today;2022-12
4. Inhibition of Chk2 promotes neuroprotection, axon regeneration, and functional recovery after CNS injury;Science Advances;2022-09-16
5. Failure of DNA double-strand break repair by tau mediates Alzheimer’s disease pathology in vitro;Communications Biology;2022-04-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3